This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Oct;9(10):543.

doi: 10.1038/nrurol.2012.169. Epub 2012 Aug 21.

Prostate cancer: Proponents of PSA screening boosted by new study

PMID: 22907388
DOI: 10.1038/nrurol.2012.169

Comment

Prostate cancer: Proponents of PSA screening boosted by new study

Mina Razzak. Nat Rev Urol. 2012 Oct.

. 2012 Oct;9(10):543.

doi: 10.1038/nrurol.2012.169. Epub 2012 Aug 21.

Author

PMID: 22907388
DOI: 10.1038/nrurol.2012.169

No abstract available

PubMed Disclaimer

Comment on

Temporal trends in cause of death among Swedish and US men with prostate cancer.
Epstein MM, Edgren G, Rider JR, Mucci LA, Adami HO. Epstein MM, et al. J Natl Cancer Inst. 2012 Sep 5;104(17):1335-42. doi: 10.1093/jnci/djs299. Epub 2012 Jul 25. J Natl Cancer Inst. 2012. PMID: 22835388 Free PMC article.
Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time.
Scosyrev E, Wu G, Mohile S, Messing EM. Scosyrev E, et al. Cancer. 2012 Dec 1;118(23):5768-76. doi: 10.1002/cncr.27503. Epub 2012 Jul 30. Cancer. 2012. PMID: 22847578

References

1. Nat Rev Urol. 2012 Jun 05;9(7):351 - PubMed
1. J Natl Cancer Inst. 2012 Sep 5;104(17):1335-42 - PubMed
1. Cancer. 2012 Dec 1;118(23):5768-76 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal